AI begins transforming precision oncology, speeding drug target discovery with AlphaFold and cutting clinical trial paperwork from months to days.

Researchers have developed a new method for designing de novo proteins with tailored properties. Their approach leverages the structure prediction capabilities of AlphaFold2, combining them with an ...

AlphaFold arrived as a technical moonshot that suddenly made protein structures feel like software rather than secrets of nature, and five years on it has rewired how laboratories plan experiments, ...

Researchers have created a platform, called SIMPL2, that revolutionizes the study of protein-protein interactions by simplifying detection while improving measurement accuracy. While protein-protein ...

Physical interactions between proteins influence anything from cell signaling and growth to immune responses, so the ability to control these interactions is of great interest to biologists.